| Principal Investigator Name: | Ronald D. Berger, M.D., Ph.D., F.A.C.C. | |
| Study Coordinator Name: | Elizabeth Robinson, R.N. | |
| Contact Phone: Study Coordinator | (410) 502 - 0517 | |
| Contact E-mail: Study Coordinator | erobin26@jhmi.edu | |
| Study Short Title: | TTOP AF | |
Study Long Title: | Tailored Treatment of Permanent Atrial Fibrillation Trial | |
IRB Number: | JH-eIRB #NA_00011212 | |
| Funding Source: | Ablation Frontiers, Inc. | |
| Summary of Trial: | To investigate the safety and efficacy of the Ablation Frontiers Cardiac Ablation System in the treatment of permanent atrial fibrillation. | |
Inclusions: | Age between 18 and 70 Patients with non-self-terminating AF lasting greater than seven (7) days but less than four (4) years with at least one failed DC cardioversion within the previous two years Failure of at least one class I or III rhythm control AAD | |
Exclusions: | Patients with structural heart disease Prior ASD or PFO closure with a device using a percutaneous approach Hypertrophic cardiomyopathy (LV septal wall thickness >1.5 cm) Any prior ablation for atrial fibrillation | |
Clinical Trial Site: | Johns Hopkins University 600 N. Wolfe Street, Carnegie 586 Baltimore, MD 21287 | |
| Compensation for Participating? | No, but parking passes will be distributed to assist with travel expenses. | |
| Start Date: | 2008 | |
| Anticipated End Date: | 2010 |
